Arrien Pharmaceuticals Company
Arrien Pharmaceuticals is a small molecule targeted therapeutics drug discovery and development company working towards targeting cell signaling pathways - A target class in treating neurodegenerative, Cancer, Inflammatory and Metabolic diseases. The Arrien is applying its proprietary platform to successfully discover a portfolio of uniquely identified pre-clinical stage programs in Parkinson's, Alzheimer's Diseases (PD, AD), Cancer, Rheumatoid Arthritis (RA), Type 2 Diabetes and Obesity diseases.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Ansonia, Connecticut, United States
Zip:
1-10
Founded Date:
2011-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
2000000
Total Funding:
Less than $1M
Estimated Revenue:
Less than $1M
Last Funding Date:
Series A
Last Funding Type:
info@arrienpharma.com
Register and Claim Ownership